FDA Inspection 1264016 — Versiti Indiana, Inc.

Versiti Indiana, Inc. — FEI 1828129

The FDA completed an inspection of Versiti Indiana, Inc. on March 11, 2025 in Lafayette, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 11, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lafayette, IN (United States)